Scotiabank's Record EPS Heads a Five-Name 52-Week High List

The Bank of Nova Scotia hit a new 52-week high of $130.44 after reporting third-quarter earnings of $3 billion and record EPS of $2.28, up 21% year-over-year, alongside new highs for Diagnos at 44 cents, Alkane Resources at $1.92, BCM Resources at 66 cents and Backstageplay at 26 cents.

Five Canadian-listed names set new 52-week highs on Wednesday, and the list is a study in how differently size shapes a breakout. At one end sits a Big Six bank clearing $3 billion of quarterly profit. At the other are three micro-cap issuers whose entire share prices are quoted in cents, moving on a regulatory clearance, a drill result and a geophysical crew arriving on site.

Scotiabank posts record EPS of $2.28

The Bank of Nova Scotia (T.BNS) reached a new 52-week high of $130.44 after reporting third-quarter results on Wednesday. Earnings came in at $3 billion for the quarter, with record earnings per share of $2.28 — a 21% increase from the same period a year earlier.

That is the kind of number that matters in absolute terms as well as relative ones. A 21% year-over-year gain in EPS at a bank of Scotiabank's size is not the product of a single quarter's trading luck; it reflects the whole revenue and provisioning mix moving in the same direction at once. Investors watching Canadian bank season will be asking the obvious follow-up: how much of the improvement came from lower credit provisions versus core revenue growth, and whether the run rate implied by a record quarter is repeatable into the fourth quarter.

In the licensed market-data feed, the BNS quote last traded at 93.59, up 0.53% from a prior close of 93.10, with a day range of 92.34 to 94.96, as of 20:00 GMT on Wednesday, 26 August 2026, when the market was closed. That figure sits well below the $130.44 Canadian-dollar high cited for the Toronto listing, a reminder that the same bank prints two very different-looking numbers depending on which line of the tape you are reading.

For context on the day's broader tone, the S&P 500 tracker (SPY) closed at $766.08, up 0.02%; the Nasdaq 100 tracker (QQQ) finished at $711.37, up 0.09%; and the Dow 30 tracker (DIA) ended at $534.23, down 0.19%. In other words, the U.S. benchmarks went nowhere. These breakouts were company-specific, not a rising-tide effect.

Diagnos clears a Saudi regulatory hurdle

Diagnos Inc (V.ADK) hit a new 52-week high of 44 cents. The catalyst is a Medical Device Marketing Authorization for the CARA System, granted in mid-August by the Saudi Food and Drug Authority.

A marketing authorization is not a sale, and that distinction is worth holding onto. What the clearance does is remove the binary risk — the possibility that a regulator says no — and open a legally addressable market. For a company whose shares trade in cents, the value of that permission depends entirely on what follows: distribution agreements, installed-base deals with hospital groups or screening programs, and recurring revenue per site. Saudi Arabia's health system has been an active buyer of screening technology, which makes the authorization strategically sensible rather than incidental. But the next disclosure investors should be looking for is a commercial contract, not another regulatory milestone.

Alkane's Cuffley Lode result and BCM's crew on the ground

Alkane Resources Ltd (T.ALK) set a new 52-week high of $1.92 after releasing exploration results that highlighted the discovery of a new high-grade zone of the Cuffley Lode, together with drilling results from the Sub-KC domain at depth below the Augusta mine and at the Costerfield property in Victoria, Australia.

This is the most materially advanced of the junior catalysts on the list, for one structural reason: Costerfield and Augusta are producing assets, not greenfield ground. High-grade intercepts found beneath an operating mine can be converted into mineable ounces using infrastructure that already exists — shafts, mills, permits, a workforce. The cost per ounce of adding reserves at depth below a working mine is typically a fraction of the cost of proving up a new district. Extending mine life at Costerfield is a direct input to net asset value in a way that an early-stage discovery is not.

BCM Resources Corp (V.B) also touched a new 52-week high, at 66 cents, after announcing last week that an aggressive geophysical survey is underway at its Thompson Knolls porphyry-skarn discovery. The contractor is Zonge International, Inc., based in Reno, Nevada, which has begun systematic ground-induced polarization and magnetotellurics surveys.

Both techniques map subsurface electrical properties: induced polarization is widely used to trace disseminated sulphide mineralization typical of porphyry copper systems, while magnetotellurics reads natural electromagnetic fields to image structures at greater depth. Neither produces metal. What they produce is drill targets. The honest framing of BCM's news is that the market is paying up for better information rather than for a resource — a rational bet on a porphyry-skarn system, but one where the re-rating comes later, if the geophysics translates into intercepts.

Backstageplay and the anatomy of a cent-priced breakout

Backstageplay Inc. (V.BP-H) hit a new 52-week high of 26 cents this week after completing a previously announced transaction. As Baystreet noted in flagging the day's breakout list, the company confirmed the closing.

Grouping a bank with four small-caps on a single list of highs is a useful exercise precisely because it exposes how unlike each other these signals are. Scotiabank's high is backed by an audited number — $3 billion of quarterly profit — that will still be there next quarter as a comparison base. The junior names are trading on the probability of future cash flows that do not yet exist, and in three of the four cases the news is procedural: a permission granted, a survey started, a deal closed.

That does not make the moves wrong. It does mean the follow-through tests are different. For Scotiabank, watch whether Q4 sustains the earnings trajectory and how the rest of Canadian bank season prints against it. For Diagnos, watch for revenue attached to the Saudi authorization. For Alkane, watch whether the Cuffley Lode zone and the Sub-KC intercepts show up in a reserve or mine-plan update. For BCM, watch the drill program that the Zonge surveys are designed to define. Highs set on news are only durable if the news becomes numbers.

Key facts

• Scotiabank 52-week high: $130.44 (T.BNS)
• BNS last trade: 93.59, +0.53%, as of 20:00 GMT Wed 26 Aug 2026 (market closed)
• Q3 record EPS: $2.28, up 21% year-over-year; quarterly earnings $3 billion
• Other new highs: Alkane $1.92, Diagnos 44c, BCM Resources 66c, Backstageplay 26c

Frequently asked questions

Why did Scotiabank shares hit a 52-week high?

The Bank of Nova Scotia reported third-quarter results on Wednesday featuring record earnings per share of $2.28, a 21% increase from a year earlier, on quarterly earnings of $3 billion. The Toronto-listed shares reached a new 52-week high of $130.44 following the release. A 21% EPS gain at a bank of that scale reflects broad improvement rather than a one-off item.

What did Diagnos announce about the CARA System?

Diagnos Inc (V.ADK) received Medical Device Marketing Authorization for its CARA System from the Saudi Food and Drug Authority in mid-August. That clearance permits the device to be marketed in Saudi Arabia. It is a regulatory permission rather than a sale, so the commercial value depends on distribution or hospital contracts that follow. The shares hit a 52-week high of 44 cents.

What is the Cuffley Lode and why does it matter to Alkane?

Alkane Resources Ltd (T.ALK) reported exploration results highlighting a new high-grade zone of the Cuffley Lode, plus drilling from the Sub-KC domain at depth below the Augusta mine and the Costerfield property in Victoria, Australia. Because Costerfield and Augusta are existing operations, high-grade intercepts nearby can potentially be mined using infrastructure already in place. The stock reached $1.92.

What survey work is BCM Resources doing at Thompson Knolls?

BCM Resources Corp (V.B) said an aggressive geophysical survey is underway at its Thompson Knolls porphyry-skarn discovery. Zonge International, Inc., based in Reno, Nevada, began systematic ground-induced polarization and magnetotellurics surveys. Both methods image subsurface electrical properties to generate drill targets; they do not define a resource on their own. BCM hit a 52-week high of 66 cents.

What does a 52-week high actually tell an investor?

It means the shares traded above any price recorded in the prior year. That is a momentum signal, not a valuation judgment. A high backed by reported profits, such as Scotiabank's $3 billion quarter, rests on audited figures. A high in a cent-priced explorer typically rests on the probability of future results, which makes the follow-through news far more important.

How did broader markets trade the same day?

As of 20:00 GMT on Wednesday, 26 August 2026, with the market closed, the S&P 500 tracker (SPY) finished at $766.08, up 0.02%. The Nasdaq 100 tracker (QQQ) closed at $711.37, up 0.09%, and the Dow 30 tracker (DIA) ended at $534.23, down 0.19%. Benchmarks were essentially flat, so the breakouts were company-specific.

Sources

• Diagnos, Alkane, BCM at 52-Week Highs on News — Baystreet

Photo: Aswin R S · Pexels Licence — source